T1	Participants 43 90	across the spectrum of acute coronary syndromes
T2	Participants 167 232	adverse cardiovascular outcomes in acute coronary syndromes (ACS)
T3	Participants 488 510	3225 patients with ACS
T4	Participants 550 671	patients who suffered an adverse cardiac outcome within 10 months of study entry and in patients who had no adverse event
